2025-06-05

(Revised) Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2025

2025-06-05

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2025

2025-05-28

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

2025-05-28

I. POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MAY 28, 2025; II. APPOINTMENT OF DIRECTOR

2025-05-27

SUPPLEMENTAL ANNOUNCEMENT - DISCLOSEABLE TRANSACTIONS IN RELATION TO SUBSCRIPTION OF WEALTH MANAGEMENT PRODUCTS

2025-05-22

VOLUNTARY ANNOUNCEMENT - UPDATES ON THE CLINICAL TRIALS OF IMM2510/AXN-2510 IN COMBINATION WITH CHEMOTHERAPY IN FIRST-LINE NSCLC

2025-05-14

Next Day Disclosure Return

2025-05-14

INSIDE INFORMATION - COMPLETION OF THE H SHARE FULL CIRCULATION BY THE COMPANY

2025-05-08

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2025

2025-05-07

VOLUNTARY ANNOUNCEMENT - FURTHER PAYMENT RECEIVED UNDER THE LICENSE AND COLLABORATION AGREEMENT WITH AXION BIO FOR IMM2510 (PALVERAFUSP) AND IMM27M (TAZLESTOBART)

2025-05-06

VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF BUSINESS OFFICER

2025-04-30

Proxy Form for the Annual General Meeting to be held on May 28, 2025

2025-04-30

NOTICE OF THE ANNUAL GENERAL MEETING

2025-04-30

CIRCULAR OF THE 2024 ANNUAL GENERAL MEETING

2025-04-25

Annual Report 2024

2025-04-24

NSIDE INFORMATION - THE H SHARE FULL CIRCULATION LISTING APPROVAL GRANTED BY THE STOCK EXCHANGE

2025-04-03

Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2025

2025-04-02

VOLUNTARY ANNOUNCEMENT - UPDATES ON THE CLINICAL TRIAL OF IMC-003/IMM72

2025-03-26

VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY EXECUTIVE DIRECTOR, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF THE BOARD

2025-03-25

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2024 AND PROPOSED CHANGE IN USE OF PROCEEDS